Product in action

Move from market opportunity to the accounts and physicians behind it.

Pick a vertical to explore a real, de-identified-at-the-manufacturer-level dataset: dashboard, facilities, physicians, and a schematic territory map — each built the same way a production engagement would be.

This explorer carries two vertical research corpora — 950 facilities and 1391 physicians in total, one national (Neurointervention) and one regional (Vascular Access & Repair). The platform is built to run at national scale across every vertical: approximately 9.5 million physicians and 3,300 hospitals.

Cardiology & Structural HeartPilot — data not yet integrated
OncologyPilot — data not yet integrated
Orthopedics & SpinePilot — data not yet integrated
Diabetes & MetabolicPilot — data not yet integrated

Stroke thrombectomy, aneurysm coiling, and flow-diversion targeting across 22 national metros' designated stroke centers.

This vertical reflects a national NPPES/CMS-sourced neurointervention research corpus: 847 facilities and 873 physicians across 22 metros, built the same way a production engagement would be — not a curated subset.

Facilities

847

Physicians

873

Research-linked payments

$25,940,992

By region

New York City metro: 49Los Angeles metro: 52Chicago metro: 63Houston metro: 36Dallas / Fort Worth: 33Philadelphia metro: 48Washington DC / Baltimore: 34Miami / South Florida: 47Boston metro: 42San Francisco Bay Area: 59Atlanta metro: 39Phoenix / Scottsdale: 31Minneapolis / St. Paul: 28Seattle / Puget Sound: 40Detroit metro: 35Denver / Front Range: 29Tampa / Orlando: 28Cleveland / Pittsburgh: 21Charlotte / Raleigh-Durham: 9San Antonio / Austin: 44St. Louis / Kansas City: 48Nashville / Memphis: 32

Top facilities

By reported annual neurovascular discharge volume

01
893 discharges
02
867 discharges
03
797 discharges
04
793 discharges
05
641 discharges
Research & investigator relationships

Total study-linked payments by manufacturer

01GlaxoSmithKline, LLC. · 21 payments · 1 physician
$14,477,616
02MicroVention, Inc. · 362 payments · 56 physicians
$2,076,990
03Medical Device Business Services, Inc. · 142 payments · 33 physicians
$1,477,407
04Balt USA, LLC · 223 payments · 19 physicians
$1,385,087
05Janssen Research & Development, LLC · 168 payments · 14 physicians
$1,365,932
06Stryker Corporation · 185 payments · 37 physicians
$1,187,794
07IRRAS USA, Inc. · 8 payments · 1 physician
$863,550
08Medtronic, Inc. · 279 payments · 58 physicians
$634,580

Study-record amounts associated with an investigator are not personal payments — see each physician's own profile for the study-level detail.

Scope and interpretation

The current demonstration uses controlled, historical healthcare evidence. It does not represent complete, real-time, all-payer, or exact named-facility procedure volume. Future licensed data layers will be labeled separately when available and validated.

Full methodology and scope notes
  • This is an illustrative, de-branded demonstration built from two real research engagements. Facility scores, physician affiliations, and industry-payment figures are sourced from public records (the NPI provider registry, CMS Open Payments, CMS Doctors & Clinicians, state trauma-designation registries) as of the dates noted in each source, not real-time or complete claims data.
  • Both verticals carry their complete source engagement, not a curated subset; see each vertical's summary and source note for exact counts.
  • The Vascular territory map places facilities schematically by named region, not by literal geocoded coordinates - a planning aid, not exact facility geography. The Neuro map uses each facility's own public-source geocoded address on a real (simplified) US outline. Neither map uses live map tiles or a third-party mapping service.
  • Cardiology, Oncology, Orthopedics & Spine, and Endocrine are shown as planned pilot verticals with no integrated data yet, not current capabilities.